Mikhail Sheila
SEC insider (Form 3/4/5 filer). CIK 0001864431. Director at Verve Therapeutics, Inc. (VERV). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 25, 2025. Located in BOSTON, MA.
Companies Mikhail Sheila has filed insider reports for
- Verve Therapeutics, Inc. (VERV): Director
Mikhail Sheila
CIK: 0001864431
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Verve Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
136.1K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
42.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
43.2K shares- - Jun 5, 2025VERV
Verve Therapeutics, Inc.
AwardDirectStock Option (right to buy)
42.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 136,139 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 42,200 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 43,198 | - | - | Direct |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | Award Stock Option (right to buy) | 42,200 | - | - | Direct |
1-4 of 4 transactions